Brown, Lisle/Cummings’s Biohaven BHVN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$313 Hold
37
﹤0.01% 1005
2025
Q4
$418 Hold
37
﹤0.01% 727
2025
Q3
$555 Hold
37
﹤0.01% 736
2025
Q2
$522 Hold
37
﹤0.01% 747
2025
Q1
$889 Hold
37
﹤0.01% 717
2024
Q4
$1.38K Hold
37
﹤0.01% 612
2024
Q3
$1.85K Hold
37
﹤0.01% 578
2024
Q2
$1.28K Buy
+37
New +$1.46K ﹤0.01% 578

Other funds holding BHVN

Brown, Lisle/Cummings's BHVN Position: Q1 2026 in Review

Brown, Lisle/Cummings held its Biohaven (BHVN) position steady in Q1 2026 at 37 shares worth $313. The position accounts for ﹤0.01% of the portfolio, ranked #1005.

Brown, Lisle/Cummings first reported a position in BHVN in Q2 2024 and has held it in 8 quarters since. The position peaked at $1.85K in Q3 2024. 275 funds tracked by Wall St. Rank hold BHVN as of Q1 2026.

  • Brown, Lisle/Cummings held 37 shares of Biohaven worth $313 as of Q1 2026.
  • Brown, Lisle/Cummings left its Biohaven share count unchanged in Q1 2026.
  • Biohaven made up ﹤0.01% of Brown, Lisle/Cummings's portfolio in Q1 2026, its #1005 holding.
  • Brown, Lisle/Cummings first reported a position in Biohaven in Q2 2024 and has held it in 8 quarters since.
  • Brown, Lisle/Cummings's Biohaven position peaked at $1.85K in Q3 2024.
  • 275 funds tracked by Wall St. Rank held Biohaven as of Q1 2026.

Based on Brown, Lisle/Cummings's 13F filing for Q1 2026, filed 20 Apr 2026.